Offerings // Lantern Pharma Inc.

LTRN offering history

Every offering-related filing in Lantern Pharma Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 262 filings back to Jan 14, 2019.

Last executed offering

Sep 30, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Jun 12, 2026

S-1 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 30, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 30, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 18, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 12, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
May 14, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 14, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 30, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 3, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 10, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 24, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 12, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 2, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 15, 2021	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Jan 15, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 14, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 11, 2021	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Jan 8, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 17, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 12, 2020	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Jun 12, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 10, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 8, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 19, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 19, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 12, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Apr 16, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

LTRN offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full LTRN workspace →

LTRN offering FAQ

When did LTRN last execute an offering?

Per SEC filings, Lantern Pharma Inc.'s most recent priced offering document is a 424B5 filed 2026-09-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did LTRN last announce or register an offering?

The most recent registration is a S-1 filed 2026-06-12. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.